Product
P2B001
2 clinical trials
2 indications
Indication
Parkinson's DiseaseIndication
Parkinson's diseaseClinical trial
A Phase 2B, Twelve-week Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study, To Determine the Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's DiseaseStatus: Completed, Estimated PCD: 2015-05-01
Clinical trial
A Phase 3, Twelve-week Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to Its Individual Components in Subjects With Early Parkinson's Disease and to a Calibration Arm of Pramipexole ER.Status: Completed, Estimated PCD: 2021-08-23